Related Experiment Video
Updated: Jul 10, 2026
12:28
Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Disease-specific quality indicators, guidelines, and outcome measures in vasculitis
1Botnar Research Centre, University of Oxford, Oxford, UK.
Clinical and Experimental Rheumatology
|November 29, 2007
Summary
Diagnosing anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) early is crucial for effective treatment. Identifying risk factors for poor outcomes in AAV patients improves survival and quality of care.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) survival has improved with immunosuppressive therapy.
- Early diagnosis of AAV is challenging due to non-specialist referrals and delayed treatment initiation.
- Quality of care measurement in AAV is complex, necessitating comprehensive assessments.
Purpose of the Study:
- To discuss quality of care in ANCA-associated vasculitides (AAV).
- To identify risk factors for poor outcomes in AAV.
- To review European League Against Rheumatism (EULAR) guidelines for AAV clinical trials.
Main Methods:
- Review of current literature and European League Against Rheumatism (EULAR) guidelines.
- Analysis of risk factors associated with disease remission, relapse, organ failure, and mortality in AAV.
- Discussion of prognostic indicators in various forms of AAV.
Main Results:
- High disease activity at diagnosis is a risk factor for mortality but may indicate better treatment response.
- Cardiac involvement in Wegener's granulomatosis, significant organ damage, renal impairment, and persistent ANCA are poor prognostic indicators.
- Elderly age, underuse of cyclophosphamide/glucocorticoids, Staphylococcus aureus nasal carriage, and cyclophosphamide-induced bladder cancer risk are also noted.
Conclusions:
- Comprehensive assessment of organ involvement is vital for specialist treatment planning and comorbidity management in AAV.
- Recognizing prognostic factors aids in managing AAV patients and improving long-term outcomes.
- Adherence to guidelines and prompt specialist intervention are key for optimizing AAV care.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:11Guidelines for Writing Outcome
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...